Chad Terhune News Today

A small but rapidly growing number of U.S. adolescents began treatment with Novo Nordisks weight-loss drug Wegovy last year, a powerful new tool to address record rates of pediatric obesity,

A small but rapidly growing number of U.S. adolescents began treatment with Novo Nordisks weight-loss drug Wegovy last year, a powerful new tool to address record rates of pediatric obesity,...

A small but rapidly growing number of U.S. adolescents began treatment with Novo Nordisks weight-loss drug Wegovy last year, a powerful new tool to address record rates of pediatric obesity,...

A small but rapidly growing number of U.S. adolescents began treatment with Novo Nordisk's <NOVOb.CO> weight-loss drug Wegovy last year, a powerful new tool to address...

By Robin Respaut and Chad Terhune (Reuters) - A small but rapidly growing number of U.S. adolescents began treatment with Novo Nordisk's weight-loss drug Wegovy last year, a powerful new tool to address record rates of pediatric obesity, according ...

Dr. Lee Kaplan took the stage with an urgent message, telling fellow physicians they have a powerful weapon to fight the American obesity crisis: their prescription pads. Counseling on...

LONDON (Reuters) - John, a tech executive who has been battling weight gain since his 30s, has a nine-month supply in his refrigerator. Kim Gradwell, a retired receptionist who developed type 2 diabetes nearly 20 years ago, isn't sure where she'll find her next dose.

John, a tech executive who has been battling weight gain since his 30s, has a nine-month supply in his refrigerator. Kim Gradwell, a retired receptionist who developed type 2 diabetes nearly 20 years...

By Maggie Fick LONDON (Reuters) - John, a tech executive who has been battling weight gain since his 30s, has a nine-month supply in his refrigerator....

“I knew it was the drug,” said Heidlebaugh, who said she had not previously suffered from depression. Heidlebaugh is one of four U.S. patients who told Reuters about experiencing suicidal thoughts while taking Novo Nordisk’s popular Ozempic drug, approved to treat type 2 diabetes, or Wegovy, another Novo top-seller approved for weight loss. A fifth patient said he experienced depression and suicidal thoughts after taking Mounjaro, a similar diabetes medicine from Eli Lilly...